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Background: Methods used for evaluation of cardiac risk before noncardiac surgery vary widely. We evaluated the effect
over time on practice and resource utilization of implementing the American College of Cardiology/American Heart
Association Guidelines on Preoperative Risk Assessment.
Methods: We compared 102 historical control patients who underwent elective abdominal aortic surgery (from January
1993 to December 1994) with 94 consecutive patients after guideline implementation (from July 1995 to December
1996) and 104 patients in a late after guideline implementation (from July 1, 1997, to September 30, 1998). Resource
use (testing, revascularization, and costs) and outcomes (perioperative death and myocardial infarction) were examined.
Patients with and without clinical markers of risk for perioperative cardiac complications were compared.
Results: The use of preoperative stress testing (88% to 47%; P < .00001), cardiac catheterization (24% to 11%; P < .05),
and coronary revascularization (25% to 2%; P < .00001) decreased between control and postguideline groups,
respectively. These changes persisted in the late postguideline group. Mean preoperative evaluation costs also fell ($1087
versus $171; P < .0001). Outcomes of death (4% versus 3% versus 2%) and myocardial infarction (7% versus 3% versus 5%)
were not significantly different between control, postguideline, and late postguideline groups, respectively. Stress test
rates were similar for patients at low risk versus high risk in the historical control group (84% versus 91%; P  .29) but
lower for patients at low risk after guideline implementation (31% versus 61%; P  .003).
Conclusion: Implementation of the American College of Cardiology/American Heart Association cardiac risk assessment
guidelines appropriately reduced resource use and costs in patients who underwent elective aortic surgery without
affecting outcomes. This effect was sustained 2 years after guideline implementation. (J Vasc Surg 2002;36:758-63.)
Cardiac events represent the most common cause of
significant morbidity and mortality after major surgery.
This is particularly true among high-risk populations, such
as those patients with peripheral vascular disease who un-
dergo surgical revascularization procedures. A number of
studies have focused on the problem of identifying those
individuals at high risk for cardiac complications during or
after vascular surgery. The results have shown that func-
tional stress testing before surgery can identify a subset of
patients with a high risk of perioperative cardiac events.1-3
This is true of treadmill testing and thallium imaging stud-
ies.4,5 These reports led to widespread (and in some insti-
tutions, universal) use of these modalities as screening
methods before major surgery in patients at high risk, such
as those undergoing surgical revascularization for periph-
eral vascular occlusive disease. Although these tests identify
patients at high risk with great sensitivity, the specificity has
been uniformly poor.6 Attention shifted to the use of
screening on the basis of clinical markers to identify indi-
viduals at low risk whose perioperative cardiac complication
rate is sufficiently low to warrant exclusion from stress
testing before surgery.7 The American College of Cardiol-
ogy/American Heart Association (ACC/AHA) Guidelines
for Preoperative Cardiac Risk Assessment have emphasized
a stepwise algorithm in the evaluation of these patients that
limits the use of preoperative stress testing to patient
groups at clinical moderate and high risk.6
The broad application of indiscriminate preoperative
stress testing adds significantly to the overall cost of surgical
revascularization. Impact of test usage on outcomes has not
been evaluated. Our belief is that the use of the ACC/AHA
preoperative risk assessment guidelines, by limiting the use
of stress testing among patient groups at clinical low risk,
could favorably affect resource utilization, without any
unfavorable effect on outcomes, such as myocardial infarc-
tion (MI) and perioperative death. Our hypothesis was that
the use of these guidelines in preoperative evaluations,
implemented through an educational program, could limit
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resource utilization. We studied this by designing and
implementing such an educational program at the Univer-
sity of Michigan Medical Center and evaluating its effect on
the resource utilization and outcomes surrounding elective
aortic surgery, both immediately after guideline implemen-
tation and 2 years later. Results then were compared with
our own prior experience.
METHODS
To establish baseline current practice with regard to
preoperative cardiac testing, we retrospectively evaluated
with chart review the resource utilization and outcomes in
102 consecutive patients who underwent elective aortic
surgery at the University of Michigan between January
1993 and December 1994. Clinical information gathered
included demographic characteristics and clinical markers
of perioperative cardiac risks, such as advanced age, gender,
history of diabetes necessitating medication, previous MI
either by history or electrocardiogram, and history of con-
gestive heart failure by history or examination. Assessment
of resource utilization included use of preoperative cardiac
stress testing, use of preoperative cardiac catheterization,
percutaneous or surgical preoperative coronary revascular-
ization, cost of the preoperative evaluation, and hospital
length of stay. Similarly, clinical outcomes were noted,
including perioperative MI or death. Patients excluded
from analysis were those who underwent urgent or emer-
gent surgery and those whose procedures extended beyond
the abdominal aorta to include thoracic aneurysm resection
or renal artery revascularization.
Perioperative MI was defined on the basis of standard
clinical, electrocardiographic, and enzymatic criteria. Peri-
operative death was defined as any death before discharge.
Preoperative evaluation cost was defined as the total of
consultation fee (if any) and costs for stress testing, cathe-
terization, or coronary revascularization procedures done,
exclusive of hospitalization costs. These costs were stan-
dardized for 1996 dollars throughout the study. For the
calculation of costs per surgical admission, cost-to-charge
ratios were developed on the basis of inpatient activity from
the Transition Systems, Inc, costing system. We applied the
“direct cost” ratios for each department to the hospital
charges for every patient encounter. This was used to
calculate the direct cost consistently over time. Direct costs
included variable direct costs and fixed direct costs but did
not include indirect, or overhead, costs.
Guideline implementation. A comprehensive edu-
cational program was instituted for the implementation of
the ACC/AHA Task Force guidelines. These educational
tools were intended to change the understanding of the
role of stress testing in the preoperative cardiac evaluation
and to develop a consensus pathway for patients scheduled
for elective aortic surgery. To this end, Cardiology Division
grand rounds lectures were held to explain the guidelines
and algorithms and the medical literature supporting their
design. Similar lectures were held for the Section of Vascu-
lar Surgery and the Department of Anesthesiology at the
University of Michigan. After these traditional educational
measures, we implemented techniques designed to put
guideline information and reminders in the hands of clini-
cians at the time of clinical decision making. A General
Medicine preoperative screening clinic was established for
the evaluation of patients undergoing elective surgery. A
data collection sheet was designed for use in this clinic and
included an outline of the preoperative evaluation algo-
rithm. Laminated pocket-sized copies of the algorithm
were produced and disseminated to the attending staff and
housestaff as part of a monthly orientation for the consul-
tation teams (Appendix, online only). In this way, preop-
erative evaluation was performed by a more focused group
of clinicians, all of whom had been exposed to the algo-
rithms and had printed copies with them when clinical
decisions were made.
Immediately after guideline implementation, the same
demographic and outcomes data were gathered for the first
100 patients undergoing aortic surgical procedures at the
University of Michigan. This process was repeated 2 years
after guideline implementation to evaluate long-term ef-
fects. Data were analyzed comparing immediate and de-
layed group patients with historical control patients. Demo-
graphic characteristics were compared, including clinical risk
factors, resource use, and clinical outcomes. These data were
analyzed for all patients, including subjects at clinical low risk.
We also compared stress test rates among patients with and
without clinical risk markers and compared functional capacity
level, when known, between those patients referred and not
referred for stress testing. Comparisons between groups were
tested for statistical significance with Fischer exact test for
binary variables and Student t test for data containing contin-
uous variables (eg, costs).
RESULTS
One hundred two consecutive patients underwent elec-
tive aortic surgery at the University of Michigan in the
historical control group. Ninety-four consecutive patients
who underwent elective aortic surgery were included in the
prospective study population immediately after implemen-
tation of the guideline algorithms (postguideline), with
104 consecutive patients beginning 2 years after implemen-
tation (late postguideline). No significant differences were
seen between the groups in age, gender distribution, or
Table I. Characteristics of subject and control groups
Variable
Controls
(n  102)
Postguideline
(n  94)
Late postguideline
(n  104)
Age (y) 65 68 69
Female gender 30 (29%) 22 (23%) 24 (23%)
Prior MI 24 (24%) 36 (38%) 30 (29%)
Diabetes 17 (17%) 10 (11%) 18 (17%)
CHF 11 (11%) 5 (5%) 14 (13%)
Occlusive aortic disease 31 (30%) 17 (18%) 20 (19%)
Aortic aneurysm 66 (65%) 73 (78%) 81 (78%)
Clinical risk index is total number of risk factors present (history of MI,
diabetes, congestive heart failure, angina or its equivalent).
CHF, Congestive heart failure.
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presence of diabetes (Table I). Significantly more patients
in the postguideline cohort versus the historical control
group had a history of MI (38% versus 24%, respectively;
P  .03). Conversely, a trend was seen toward more
patients with a history of congestive heart failure (5% versus
11%) in the historical control group compared with the
initial cohort of patients. No significant differences were
seen between the late postguideline cohort of patients and
the historical control group (Table I). All three groups had
similar types of disease and surgery as well (Table I).
Resource utilization dropped markedly in those patients
studied prospectively compared with the historical control
patients (Table II). A significant decrease was seen in the
utilization of all stress tests after implementation of the guide-
lines. Among historical control patients, 90 patients (88%)
underwent preoperative stress testing compared with 45
(47%) in the initial postguideline cohort (P .001). Utiliza-
tion of preoperative catheterization dropped from 24 (24%)
for the historical control cohort to 10 (11%; P .02). Rates of
coronary revascularization fell dramatically (Table II). Com-
bined rates of percutaneous transluminal coronary angioplasty
or coronary artery bypass grafting went from 25% among
historical control patients to 2% in guideline-managed pa-
tients (P  .001). Total cost per patient of preoperative
evaluation fell from $1087 to $171 in the initial cohort (P
.001). Although not originally defined as a primary endpoint,
length of stay decreased from 20.7 days to 13.2 days on
average (P  .001), as did cost per case of the surgical
admission ($21,947 to $15,188; P .02).
The incidence rates of perioperative death and MI did
not differ significantly between the historical and post-
guideline groups (Table II). The rates of perioperative
death were 4% in historical control patients versus 3% in the
postguideline cohort of patients (P  .77 versus historical
control group). The perioperative MI rate was 7% in the
historical control group versus 3% in the initial postguide-
line group (P  .24). Death or MI was seen in 11% of
control patients versus 4% in the initial guideline cohort
(P  .08).
We next examined resource use and outcome in the
patients at low clinical risk by excluding patients with any of
the following conditions: a history of MI by electrocardio-
gram or history, diabetes with medical therapy, congestive
heart failure by history or examination, or a history of
angina (Table III). There were 45 patients at low risk in the
postguideline cohort and 57 in the historical control group.
Stress test utilization among these patients at clinical low
risk was markedly decreased in the postguideline cohort, to
almost one third the historical control rate (33% versus
91%; P  .00001). Rates of percutaneous transluminal
coronary angioplasty, coronary artery bypass grafting, and
preoperative catheterization were reduced as well, although
most of these differences failed to reach statistical signifi-
cance because of the small number of these procedures.
The type of surgery did not differ significantly between the
prospective group and the historical control group, and
outcomes of death and MI were similarly distributed. No
deaths or MIs were observed during the cardiac evaluations
or coronary revascularizations.
For the assessment of guideline implementation impact
on decision making and for the evaluation of whether stress
test use was in fact more appropriate, we compared rates of
stress test utilization in patients both with and without
Table II. Resource use and outcomes after implementation of ACC/AHA preoperative risk assessment guidelines
Resource utilization
I II III P value P value
Controls
(n  102)
Postguideline
(n  94)
Late postguideline
(n  104) (I versus II) (I versus III)
Stress test 90 (88%) 44 (47%) 43 (41%) .001 .001
Coronary angiography 24 (24%) 10 (11%) 11 (11%) .05 .01
PTCA or CABG 24 (24%) 2 (2%) 6 (6%) .001 .001
LOS (days) 20.7 13.2 .001
Preoperative cost $1087 $171 .001
Cost per case $21,947 $15,188 .02
Outcomes
Death 4 (4%) 3 (3%) 0 .77
MI 7 (7%) 3 (3%) 5 (5%) .24
Death or MI 11 (11%) 4 (4%) 5 (5%) .08
PTCA, Percutaneous transmural coronary angioplasty; CABG, coronary artery bypass grafting; LOS, length of stay.
Table III. Resource use and outcomes in patients and
controls, excluding subjects with MI, diabetes mellitus,
congestive heart failure, or chest pain (angina or its
equivalent)
Resource
utilization
Controls
(n  57)
Postguidelines
(n  45) P value
Stress test 52 (91%) 14 (31%) .001
Coronary
angiography
12 (21%) 3 (7%) .04
PTCA 4 (7%) 1 (2%) .25
CABG 3 (5%) 1 (2%) .42
PTCA or CABG 7 (12%) 2 (4%) .16
Outcomes
Death 1 (2%) 0 .37
MI 3 (5%) 1 (2%) .42
PTCA, Percutaneous transluminal coronary angioplasty; CABG, coronary
artery bypass grafting.
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clinical risk factors in the postguideline cohort and histori-
cal control group (Figs 1 and 2). Stress test rates were high
in historical control patients, for both the low and high
clinical risk groups (84% and 91%; P .29). After guideline
implementation, the stress testing rate for patients at clini-
cal high risk was double that of the low-risk group (61%
versus 31%, respectively; P .003). Furthermore, for those
patients with functional status recorded, significantly more
patients who did not undergo stress testing had functional
capacities of more than 5 metabolic equivalents in both the
low clinical risk group (82% versus 22%; P .003) and the
higher clinical risk group (77% versus 25%; P  .003).
Finally, we compared demographics, resource utiliza-
tion, and outcomes for the late postguideline cohort versus
the postguideline cohort (Tables I and II). No demo-
graphic differences were seen between these two cohorts,
except for a slightly higher incidence rate of congestive
heart failue in the late postguideline cohort, which was
similar to that of the historical control group (Table I).
Resource utilization was identical between the initial post-
guideline cohort and the group that underwent surgery 2
years after guideline implementation. Rates of stress test
utilization, preoperative coronary catheterization and re-
vascularization, and perioperative death and MI were un-
changed compared with the initial postguideline cohort
(Table III). Death and MI rates were virtually unchanged
for all three cohorts. MI rate was 7% for historical controls
and 3% and 5% for the postguideline and late postguideline
cohorts, respectively (P  .39 and .40). Death or MI
occurred in 11% of historical controls versus 4% and 5% in
postguideline and late postguideline cohorts, respectively
(P  .56 and .10).
DISCUSSION
This study demonstrates decreased utilization of car-
diac stress testing, and coronary revascularization proce-
dures after the institution-wide introduction, with simple
educational tools, of the ACC/AHA Joint Task Force
Guidelines for Preoperative Risk Assessment. The impact of
this program was significant, decreasing resource utiliza-
tion by as much as 50% and cost of preoperative evaluation
by approximately 75%. This was particularly true among the
patient populations at clinical low risk (ie, those without
any identified clinical markers for cardiac complications). It
Fig 2. Clinical risk and stress test use in patients for aortic surgery after guideline implementation. Functional
capacity was prospectively identified in 67 of 94 patients at initial guideline. This comparison examines stress test use in
only these 67 individuals.
Fig 1. Clinical risk and stress test use in patients for aortic surgery before guideline implementation.
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 4 Froehlich et al 761
is in this patient group that the guideline algorithms argue
for conservative application of expensive tests and treat-
ment. These data also suggest that stress tests were more
appropriately applied after implementation of the guide-
lines. Patients with clinical markers of perioperative risk
were more likely to undergo stress testing after guideline
implementation. Where recorded, patient functional status
correctly predicted the use of stress testing, as recom-
mended by the guidelines. Low functional status correlated
strongly with the likelihood of undergoing stress testing,
regardless of the patient’s clinical risk profile. Although this
study was not sufficiently powered to detect modest
changes in outcomes, we observed no difference, and in fact
a slight decrease, in the rate of perioperative MI or death
after guideline implementation. Evaluation of resource uti-
lization and outcomes 2 years after implementation of
guidelines revealed a sustained effect. Specifically, reduc-
tions in resource utilization from reduced stress testing,
cardiac catheterization, and revascularization were main-
tained at initial levels, even 2 years after the AHA/ACC
preoperative guidelines were introduced.
Although several studies have shown a high sensitivity
of dipyridamole-thallium and dobutamine-echocardiogra-
phy stress testing for identification of patients at high risk
for perioperative cardiac events during vascular sur-
gery,1,8-10 a metaanalysis of 17 studies revealed a low
specificity.6 In spite of a poor positive predictive value in
unselected patients, thallium testing became universal in
many institutions. Several studies have focused on the
ability of clinical assessment to augment stress testing in
assessment of perioperative risk. Hubbard et al11 from the
Mayo Clinic found that age, diabetes, angina, male gender,
and history of MI all strongly correlated with the presence
of either three-vessel or left main coronary artery disease.
Eagle et al3 identified and then validated clinical criteria to
stratify perioperative cardiac risk after elective vascular sur-
gery as low, medium, and high. The absence of these
criteria (diabetes, age more than 70 years, history of MI,
history of congestive heart failure, and history of chest pain)
was shown to identify a group at low risk for cardiac
complications of surgery, without necessity of further func-
tional study. This was further supported in a validation
cohort reported by Cambria and coinvestigators7 at the
Massachusetts General Hospital. Poldermans et al9 found
that patients with no clinical markers of risk received no
benefit from stress testing. From the opposite perspective,
Vanzetto et al12 showed that high-risk subsets of patients
who underwent aortic surgery would derive further benefit
from stress testing. They reported that among patients at
higher clinical risk, reversible defects on thallium imaging
were associated with a major cardiac event rate of 8.2%,
versus 1.2% in patients without thallium abnormalities. This
concept was taken further when L’Italien et al13 showed that
the clinical pretest probability of significant cardiac disease
could be quantified in a Bayesian prediction model to identify
those patients at moderate risk who were likely to benefit from
stress testing and also the patients at low and high risk who
would not. Finally, a study by Bartels et al14 described the use
of an evaluation strategy similar to the ACC/AHA guidelines
based on an assessment of clinical risk and functional capacity
in 203 patients scheduled for aortic surgery. They reported an
overall mortality rate of 3.5% and a cardiac mortality rate of
1%, in spite of selective use of noninvasive testing in only 20%
of 203 patients. Vanzetto et al12 showed that thallium testing
helped to further define risk in clinically high risk subgroups.
More invasive testing, however, may be less useful. Massie et
al15 found no improvement in outcomes in patients with
scintographic abnormalities who underwent cardiac catheter-
ization compared with matched control subjects who did not.
Taken together, these studies support the ACC/AHA guide-
lines concept of an algorithm for clinical evaluation of cardiac
risk, followed by selective testing in higher risk subgroups of
patients.
The ACC/AHA Joint Task Force guidelines describe a
stepwise algorithm on the basis of the previous concepts.
The clinical history, including any previous cardiac assess-
ment or revascularization, is used to identify patients at
sufficient risk to warrant further evaluation on functional
testing. This is based on the presence of risk factors, the
patient’s functional capacity, and the type of operation
planned. More importantly, these combined criteria may be
used to identify patients at sufficiently low risk to justify
surgery without further functional testing. The results of
this study, although it contained small numbers of subjects,
support this concept. Preoperative testing was reduced,
particularly among the patients at low risk in accordance
with the guideline suggestions, without any untoward ef-
fect on perioperative MI or death.
The importance of this algorithmic approach is high-
lighted by the recent studies by Boersma et al16 and Polder-
man et al17 who showed in patients who underwent vascu-
lar surgery that dobutamine stress echocardiography was
only useful among those with intermediate or high clinical
risk and that selective use of -blockers, on the basis of both
clinical and limited dobutamine stress testing, may decrease
cardiac complications of surgery in some groups. These
studies validate the utility of selective preoperative testing
on clinical grounds and highlight the importance of risk
stratification to appropriately deliver perioperative therapy.
We believe several factors are responsible for the appar-
ent success of this intervention. This intervention was de-
signed to address problems of patient throughput in the
preoperative period, as much as to change physician behav-
ior. One focus of the study’s intervention was to facilitate
prompt clinical evaluation of these patients before the
ordering of any functional study. A second important ele-
ment in this study’s educational intervention was to estab-
lish guideline-based decision making at the level of patient
care. The algorithm-embedded clinic notes, laminated
pocket algorithm cards, and monthly orientations given to
the actual providers of care produced a ready and systematic
reminder of the clinical algorithms at the precise moment of
clinical decision making.
Implementation of guidelines meant to alter physician
behavior often yields meager or unsustainable results. We
believe educational efforts to implement guidelines should
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be simple, focused at the level of patient care, supported by
literature, and endorsed by recognized opinion lead-
ers.18,19 Effectiveness studies have documented the ability
of practice guidelines to identify cardiac patients at low
clinical risk for more conservative treatment.20,21 Persis-
tent, personal contact or “reminders” have been shown to
be essential additions to educational guidelines.22,23
This study has several limitations. It involves a single
institution’s evaluation of guideline implementation with his-
torical controls. Thus, local effects of individual opinions and
leadership may have been responsible for some of the success
achieved. Furthermore, use of historical controls leaves open
the possibility that changes in the medical literature and pre-
vailing opinions may have accounted for some of the observed
improvements. Unfortunately, randomization would be diffi-
cult to achieve within a single institution, given the enormous
potential for contamination bias. This study does support the
feasibility and potential utility of a multicenter study to further
evaluate the guideline implementation successes achieved.
Also, the effect of guideline implementation strategies is al-
ways subject to the secular effects of changes in the medical
care environment and dissemination of medical information
through other sources. Finally, misclassification of endpoints,
such as diagnosis of MI, may have occurred because no
routine surveillance protocol was used.
In conclusion, this study shows that the implementa-
tion of the ACC/AHA Preoperative Cardiac Risk Assess-
ment Guidelines with a simple educational program can
reduce resource utilization (in the form of stress testing,
coronary intervention, and cost) without increasing periop-
erative death or myocardial events in patients who undergo
elective aortic surgery. Resource use was not only reduced
but was more appropriate. These process improvements
were sustained over 2 years after guideline implementation.
These findings argue for significant opportunity to reduce
resource utilization surrounding preoperative cardiac as-
sessment in “high-use” centers. Larger studies will be
needed to assess the impact on short-term and long-term
outcomes. Further study will also be needed to assess the
reproducibility and sustainability of these results.
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